amitriptyline has been researched along with Acute Ischemic Stroke in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pigretti, SG | 1 |
| Isaac, C | 1 |
| Cea, C | 1 |
| Esnaola, MM | 1 |
| Riveros, M | 1 |
| Tejada Jacob, V | 1 |
| Weinberg, M | 1 |
| Posadas Martinez, ML | 1 |
| Cirelli, D | 1 |
| Burgos, MA | 1 |
| Zimerman, M | 1 |
| Romano, M | 1 |
1 review available for amitriptyline and Acute Ischemic Stroke
| Article | Year |
|---|---|
[Pharmacological treatment in early rehabilitation after ischemic stroke].
Topics: Amitriptyline; Antipsychotic Agents; Citalopram; Humans; Ischemic Stroke; Medicine | 2023 |